PRME FY 2024 Earnings — Prime Medicine, Inc. Revenue & Financial Results | Market Cap Arena

PRMEPrime Medicine, Inc.

$771M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M

Gross Profit

$3M100.0% margin

Operating Income

-$202M-6787.4% margin

Net Income

-$196M-6566.6% margin

EPS (Diluted)

$-1.65

Cash Flow

Operating Cash Flow

-$123M

Free Cash Flow

-$130M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$298M

Total Liabilities

$144M

Stockholders' Equity

$153M

Cash & Equivalents

$182M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$0	—
Gross Profit	$3M	$0	—
Operating Income	-$202M	-$205M	+1.1%
Net Income	-$196M	-$198M	+1.1%